About this page
KROS — Keros Therapeutics
Why Keros Therapeutics (KROS) moved: the last session's move split into the market, its industry, its themes and the part unique to the company, with our latest explained moves and their sources, beside the live chart.
On Friday, November 20, 2026, Keros Therapeutics (KROS) fell 2.72% at the close. Where it came from: Market (SPY) -4.33%, Biotechnology +1.17%, Factors (6) +0.23%, Unique to KROS +0.21%. The market drove most of KROS's decline.
Fell with the market: chipmakers led it lower on Anthropic headlines (Yahoo). The stories that moved the market.
Keros Therapeutics (KROS) last reported earnings on Thursday, November 5, 2026, after the close (SEC 8-K); the next session, Friday, November 6, 2026, KROS fell 0.95% at the close. Its next report is estimated for about Wednesday, February 3, 2027 (between February 1 and February 5), after the close, from its own rhythm across 10 reports; not yet announced. The earnings calendar.
TickerTiles has explained one of KROS's moves in the last six months — Tuesday, November 17, 2026 (rose 12.8%). The catalyst behind each, with its sources, is on this page.
Each explained move has its own page: Tuesday, November 17, 2026.
Only on this page: KROS's split updating every minute while the market is open, which of the 6 factors moved it and by how much, and the catalyst behind its explained move, with sources.
Explore daily moves on this page shows where KROS's moves came from, session by session — the market, its industry, its themes, its factors and its own part. The month and three-month views are free; six months, the year to date and the full year, with every day's breakdown and its full explanation, are part of TickerTiles Plus.
All stocks: Why stocks moved. The whole market: Market Overview.